For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.
Matt Hewitt
Advertisement
Matt Hewitt is executive director, Scientific Services Cell and Gene Therapy at Charles River.
Articles by Matt Hewitt
Advertisement
Latest Updated Articles
The Road to Personalized Medicine: Reimagining Drug ManufacturingPublished: September 15th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
